Ganirelix is an injectable competitive gonadotropin-releasing hormone antagonist. It is used as a fertility treatment drug for people with ovaries. Reference standards of Ganirelix API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Ganirelix
Catalogue No.:PA 07 35000
CAS :
Molecular Formula : C80H113ClN18O13
Molecular Weight : 1570.40
N-Acetyl-3-(2-naphthalenyl)-D-alanyl-4-chloro-D-phenylalanyl-3-(3-pyridinyl)-D-alanine
Catalogue No.:PA 07 35510
Molecular Formula : C32H31ClN4O5
Molecular Weight : 587.07
N-((S)-1-Amino-1-oxopropan-2-yl)-1-((2S,8R,11S,14S,17R,20R)-20-(4-chlorobenzyl)-2,8-bis(4-((E)-2,3-diethylguanidino)butyl)-11-(4-hydroxybenzyl)-14-(hydroxymethyl)-5-isobutyl-4,7,10,13,16,19,22-heptaoxo-17-(pyridin-3-ylmethyl)-3,6,9,12,15,18,21-heptaazatricosan-1-oyl)pyrrolidine-2-carboxamide
Catalogue No.:PA 07 35520
Molecular Formula : C67H102ClN17O12
Molecular Weight : 1373.09
(4R,7R,10R,13S,16S)-16-(4-(tert-Butoxy)benzyl)-7-(4-chlorobenzyl)-13-(isopropoxymethyl)-4-(naphthalen-2-ylmethyl)-2,5,8,11,14-pentaoxo-10-(pyridin-3-ylmethyl)-12-oxa-3,6,9,15-tetraazaheptadecan-17-oic Acid
Catalogue No.:PA 07 35530
Molecular Formula : C51H58ClN5O10
Molecular Weight : 936.49
tert-Butyl ((3Z,10S,16R,22Z)-10-(2-(((R)-1-amino-1-oxopropan-2-yl)carbamoyl)pyrrolidine-1-carbonyl)-4,22-bis(ethylamino)-13-isobutyl-12,15-dioxo-3,5,11,14,21,23-hexaazapentacosa-3,22-dien-16-yl)carbamate
Catalogue No.:PA 07 35540
Molecular Formula : C41H78N12O7
Molecular Weight : 851.13
Mono-Acetyl-Ganilelix
Catalogue No.:PA 07 35550
Molecular Formula : C82H115ClN18O14
Molecular Weight : 1612.36
Di-Acetyl- Ganilelix
Catalogue No.:PA 07 35560
Molecular Formula : C84H119ClN18O15
Molecular Weight : 1656.41
(S)-2-((S)-2-((R)-2-Acetamido-3-(naphthalen-2-yl)propanamido)-3-(4-chlorophenyl)propanamido)-3-(pyridin-3-yl)propanoic Acid
Catalogue No.:PA 07 35570
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
